Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (31-40 of 372) with videos related to

Pageof 38
Sort By:
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instabilityJohn I Risinger, G V R Chandramouli, G Larry Maxwell, et al.
Obstetrics and Gynecology|December 23, 2009
High poly(adenosine diphosphate-ribose) polymerase expression and poor survival in advanced-stage serous ovarian cancerJason C Barnett, Sarah M Bean, John M Nakayama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group StudyLaura Havrilesky, kathleen M Darcy, Hasnah Hamdan, et al.
Cancer Causes & Control : CCC|September 1, 2005
Anthropometric measurements and epithelial ovarian cancer risk in African-American and White womenCathrine Hoyo, Andrew Berchuck, Susan Halabi, et al.
Gynecologic Oncology Reports|November 30, 2023
Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case seriesBenjamin B Albright, Stephanie Shuey, Angeles Alvarez Secord, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|March 6, 2010
Robotic-assisted laparoscopic gynecologic procedures in a fellowship training programPaula S Lee, Amy Bland, Fidel A Valea, et al.
Gynecologic Oncology|September 30, 2011
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancerAmy E Bondurant, Zhiqing Huang, Regina S Whitaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survivalJohnathan M Lancaster, Robyn Sayer, Carrie Blanchette, et al.
Journal of Surgical Case Reports|January 4, 2021
Surgical management of ovarian carcinosarcoma with inferior vena cava extension into the right atriumAkeel M Merchant, Mark D Friedland, Marcus A Behrens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancerRobert M Wenham, Joellen M Schildkraut, Kia McLean, et al.
Pageof 38

Showing results (31-40 of 372) with videos related to

Sort By:
Pageof 38
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instabilityJohn I Risinger, G V R Chandramouli, G Larry Maxwell, et al.
Obstetrics and Gynecology|December 23, 2009
High poly(adenosine diphosphate-ribose) polymerase expression and poor survival in advanced-stage serous ovarian cancerJason C Barnett, Sarah M Bean, John M Nakayama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group StudyLaura Havrilesky, kathleen M Darcy, Hasnah Hamdan, et al.
Cancer Causes & Control : CCC|September 1, 2005
Anthropometric measurements and epithelial ovarian cancer risk in African-American and White womenCathrine Hoyo, Andrew Berchuck, Susan Halabi, et al.
Gynecologic Oncology Reports|November 30, 2023
Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case seriesBenjamin B Albright, Stephanie Shuey, Angeles Alvarez Secord, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|March 6, 2010
Robotic-assisted laparoscopic gynecologic procedures in a fellowship training programPaula S Lee, Amy Bland, Fidel A Valea, et al.
Gynecologic Oncology|September 30, 2011
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancerAmy E Bondurant, Zhiqing Huang, Regina S Whitaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survivalJohnathan M Lancaster, Robyn Sayer, Carrie Blanchette, et al.
Journal of Surgical Case Reports|January 4, 2021
Surgical management of ovarian carcinosarcoma with inferior vena cava extension into the right atriumAkeel M Merchant, Mark D Friedland, Marcus A Behrens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancerRobert M Wenham, Joellen M Schildkraut, Kia McLean, et al.
Pageof 38